Converge International has acquired HeadUp Labs
The shareholders of HeadUp Labs have sold the company to Converge International. The acquisition of HeadUp is a strong fit with Converge’s digital product growth strategy, and has the potential to create a fully integrated and holistic preventative workplace mental health, safety, wellbeing and engagement product.
Converge is Australia’s most established B2B workplace mental health and wellbeing service provider, enabling corporate and government organizations to provide their employees with the wellbeing support they need, reducing risk, improving employee resilience and increasing workforce participation.
Headquartered in Melbourne, Australia, HeadUp Labs is a physical and mental digital health platform. It harnesses the power of wearable technology, data science, AI and machine learning to help employees and policy holders identify the areas of their health that they need to improve. HeadUp Labs has offices around the world and the team has 20+ years of experience in healthtech and insurtech.
Oaklins’ team in Australia acted as M&A advisor to Converge International on the acquisition of HeadUp Labs.



Terry Winters
Chairman, Converge International
Talk to the deal team

Related deals
SulAmérica and Rede D’Or São Luiz have announced a combination
SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.
Learn moreAgar Scientific has been acquired by Calibre Scientific
Agar Scientific Ltd. (Agar) has been sold to Molecular Dimensions Limited, a subsidiary of Calibre Scientific, Inc., a US-based life sciences company, owned by international private investment firm StoneCalibre.
Learn moreCooper Consumer Health has sold Stardea to EA Pharma
Cooper Consumer Health has sold Stardea to EA Pharma.
Learn more